摘要 |
The present invention concerns compounds of formula (I) a stereochemically isomeric form thereof, an N-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, wherein -Z<SUP>1</SUP>-Z<SUP>2</SUP>- is a bivalent radical; R<SUP>1</SUP>, R<SUP>2 </SUP>and R<SUP>3 </SUP>are each independently selected from hydrogen, C<SUB>1-6</SUB>alkyl, hydroxy, halo and the like; or when R<SUP>1 </SUP>and R<SUP>2 </SUP>are on adjacent carbon atoms, R<SUP>1 </SUP>and R<SUP>2 </SUP>taken together may form a bivalent radical of formula; Alk is optionally substituted C<SUB>1-6</SUB>alkanediyl; the bivalent radical is a substituted piperidinyl, an optionally substituted pyrrolidinyl, homopiperidinyl, piperazinyl or tropyl; R<SUP>5 </SUP>is a radical of formula wherein n is 1 or 2; p<SUP>1 </SUP>is 0, and p<SUP>2 </SUP>is 1 or 2; or p<SUP>1 </SUP>is 1 or 2, and p<SUP>2 </SUP>is 0; X is oxygen, sulfur or -NR<SUP>9</SUP>; Y is oxygen or sulfur; R<SUP>7 </SUP>is hydrogen, C<SUB>1-6</SUB>alkyl, C<SUB>3-6</SUB>cycloalkyl, phenyl or phenylmethyl; R<SUP>8 </SUP>is C<SUB>1-6</SUB>alkyl, C<SUB>3-6</SUB>cycloalkyl phenyl or phenylmethyl; R<SUP>9 </SUP>is cyano, C<SUB>1-6</SUB>alkyl, C<SUB>3-6</SUB>cyclo-alkyl, C<SUB>1-6</SUB>alkyloxycarbonyl or aminocarbonyl; R<SUP>10 </SUP>is hydrogen or C<SUB>1-6</SUB>alkyl; and Q is a bivalent radical. Processes for preparing said products, formulations comprising said products and their use as a medicine are disclosed, in particular for treating conditions which are related to impaired fundic relaxation.
|